Process View
The appearance of vascular endothelial growth factor production due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "vascular endothelial growth factor production"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| VEGFA | vascular endothelial growth factor A | 0.762 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.617 | Human | |
| IL1R1 | interleukin 1 receptor, type I | 0.611 | ||
| AHR | aryl hydrocarbon receptor | 0.536 | ||
| NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.472 | ||
| IL1B | interleukin 1, beta | 0.410 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.372 | Human | |
| NRP1 | neuropilin 1 | 0.325 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.298 | Human | |
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.167 | ||
| PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 0.166 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.115 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.094 | ||
| IL6R | interleukin 6 receptor | 0.080 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.076 | Human | |
| PGF | placental growth factor | 0.076 | ||
| CLOCK | clock homolog (mouse) | 0.073 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.069 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.066 | Human | |
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.065 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.065 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.065 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.058 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.049 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.046 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.042 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.039 | ||
| KITLG | KIT ligand | 0.036 | ||
| CD86 | CD86 molecule | 0.034 | ||
| APOE | apolipoprotein E | 0.034 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.034 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.032 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.032 | ||
| IL8 | interleukin 8 | 0.028 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.027 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.025 | ||
| CFH | complement factor H | 0.025 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.024 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.022 | ||
| STAB1 | stabilin 1 | 0.022 | ||
| CLEC4A | C-type lectin domain family 4, member A | 0.021 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.021 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.020 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.019 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.019 | ||
| LAT | linker for activation of T cells | 0.018 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.017 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.017 | Rat | |
| SP1 | Sp1 transcription factor | 0.017 | ||
| TBX5 | T-box 5 | 0.017 | ||
| BCL2A1 | BCL2-related protein A1 | 0.017 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.016 | ||
| VCAN | versican | 0.016 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.016 | Human | |
| TLR2 | toll-like receptor 2 | 0.016 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.016 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.015 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.014 | Human | |
| LDLR | low density lipoprotein receptor | 0.014 | ||
| FPR1 | formyl peptide receptor 1 | 0.014 | ||
| FGL2 | fibrinogen-like 2 | 0.014 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.014 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.014 | ||
| NOG | noggin | 0.014 | ||
| SLA | Src-like-adaptor | 0.014 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.013 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.013 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.013 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.013 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.013 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.013 | ||
| VEGFC | vascular endothelial growth factor C | 0.013 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.012 | ||
| STC1 | stanniocalcin 1 | 0.012 | ||
| PDGFC | platelet derived growth factor C | 0.012 | ||
| AQP9 | aquaporin 9 | 0.012 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.012 | Mouse | |
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.012 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.011 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.011 | ||
| CD163 | CD163 molecule | 0.011 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.011 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.011 | ||
| PLEK | pleckstrin | 0.011 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.011 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.011 | ||
| GREM1 | gremlin 1 | 0.011 | ||
| CD93 | CD93 molecule | 0.011 | ||
| HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 0.011 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.010 |